Source:http://linkedlifedata.com/resource/pubmed/id/16415533
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2006-1-17
|
pubmed:abstractText |
Fluconazole (FLCZ) is an antifungal agent that is efficacious in the treatment of fungal peritonitis. Fosfluconazole (F-FLCZ) is the phosphate prodrug of FLCZ, which is highly soluble compared with FLCZ. F-FLCZ is useful against fungal peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients because it has a high water solubility. The aims of the present study were to characterize the peritoneal permeability of FLCZ and the pharmacokinetics of FLCZ and F-FLCZ after intraperitoneal (i.p.) administration to peritoneal dialysis rats. FLCZ or F-FLCZ was administered intravenously and intraperitoneally. After the i.p. administration of F-FLCZ, FLCZ was detected in circulating blood and the dialyzing fluid in peritoneal dialysis rats. The concentration of plasma FLCZ after the i.p. F-FLCZ administration was lower than that after the intravenous (i.v.) F-FLCZ administration. It is considered that the dose should be increased appropriately when F-FLCZ is administered intraperitoneally. The profiles of plasma FLCZ after i.v. and i.p. administrations were analyzed using a two-compartment model in which the distribution volume of the peripheral compartment was fixed at a volume of the dialyzing fluid (peritoneal dialysis PK model). The peritoneal dialysis PK model could describe the profiles of plasma and dialyzing fluid FLCZ. These results suggest that FLCZ and F-FLCZ could be administered intraperitoneally for the treatment of fungal peritonitis in CAPD patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alkaline Phosphatase,
http://linkedlifedata.com/resource/pubmed/chemical/Antifungal Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Fluconazole,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoric Acid Esters,
http://linkedlifedata.com/resource/pubmed/chemical/fosfluconazole
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1347-4367
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
485-90
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:16415533-Acute Kidney Injury,
pubmed-meshheading:16415533-Algorithms,
pubmed-meshheading:16415533-Alkaline Phosphatase,
pubmed-meshheading:16415533-Animals,
pubmed-meshheading:16415533-Antifungal Agents,
pubmed-meshheading:16415533-Area Under Curve,
pubmed-meshheading:16415533-Chromatography, High Pressure Liquid,
pubmed-meshheading:16415533-Data Interpretation, Statistical,
pubmed-meshheading:16415533-Fluconazole,
pubmed-meshheading:16415533-Injections, Intraperitoneal,
pubmed-meshheading:16415533-Injections, Intravenous,
pubmed-meshheading:16415533-Male,
pubmed-meshheading:16415533-Peritoneal Dialysis, Continuous Ambulatory,
pubmed-meshheading:16415533-Phosphoric Acid Esters,
pubmed-meshheading:16415533-Rats,
pubmed-meshheading:16415533-Rats, Wistar
|
pubmed:year |
2005
|
pubmed:articleTitle |
Pharmacokinetics of fluconazole and fosfluconazole after intraperitoneal administration to peritoneal dialysis rats.
|
pubmed:affiliation |
Department of Clinical Pharmacology and Toxicology, Showa Pharmaceutical University, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article
|